Regulation of nucleic acid expression by heparan sulfate and biological equivalents thereof
US6221855A · kind A · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 11, 1999 |
| Grant date | Apr 24, 2001 |
| Priority date | — |
| Expiry date | Mar 11, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of heparan sulfate, or a biological equivalent thereof, to regulate nucleic acid expression, expression of cell receptors, and infection by hepatitis B virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.